VeriMomБезопасен ли peg-6 sesqui(benzotriazolyl t-butyl hydroxyphenylpropionate) при беременности?
No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR safety assessment for this specific PEG-6 sesqui(benzotriazolyl t‑butyl hydroxyphenylpropionate) was identified in available regulatory sources. There are no published reproductive or developmental toxicity data specific to this ingredient in PubMed; by default and given its PEGylated UV‑absorber structure the concern is low but dermal exposure is expected to be low but measurable (CosIng / ECHA registration information typically indicate topical use/low dermal absorption for large PEG‑conjugates). Sources consulted: ECHA (registrations/C&L), PubChem, CosIng, PubMed.
Related ingredients
Frequently asked questions
- Безопасен ли peg-6 sesqui(benzotriazolyl t-butyl hydroxyphenylpropionate) при беременности?
- No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR safety assessment for this specific PEG-6 sesqui(benzotriazolyl t‑butyl hydroxyphenylpropionate) was identified in available regulatory sources. There are no published reproductive or developmental toxicity data specific to this ingredient in PubMed; by default and given its PEGylated UV‑absorber structure the concern is low but dermal exposure is expected to be low but measurable (CosIng / ECHA registration information typically indicate topical use/low dermal absorption for large PEG‑conjugates). Sources consulted: ECHA (registrations/C&L), PubChem, CosIng, PubMed.
- Безопасен ли peg-6 sesqui(benzotriazolyl t-butyl hydroxyphenylpropionate) при грудном вскармливании?
- No data identified showing reproductive or lactation toxicity or transfer in breast milk for this ingredient. Mechanistic or animal evidence of transfer into milk was not found; expected systemic exposure from topical cosmetic use is low but measurable, so marginal potential for maternal systemic exposure exists. Sources consulted: ECHA (registrations/C&L), PubChem, CosIng, PubMed.
- Безопасен ли peg-6 sesqui(benzotriazolyl t-butyl hydroxyphenylpropionate) для кожи малыша?
- No infant‑specific toxicity or developmental data were identified. Because the ingredient is a PEGylated benzotriazole UV‑absorber (moderate molecular size) and topical absorption in infants is typically higher than in adults, exposure score is increased by +1 for baby skin; however no evidence was found indicating intrinsic reproductive/developmental hazard. Sources consulted: ECHA (registrations/C&L), PubChem, CosIng, PubMed, EWG.
- Как VeriMom оценивает peg-6 sesqui(benzotriazolyl t-butyl hydroxyphenylpropionate)?
- VeriMom оценивает peg-6 sesqui(benzotriazolyl t-butyl hydroxyphenylpropionate) в 93/100 (без известных рисков) на основе EU CosIng, классификаций ECHA и исследований PubMed.
- Какие безопасные альтернативы peg-6 sesqui(benzotriazolyl t-butyl hydroxyphenylpropionate) при беременности?
- См. наш список безопасных альтернатив peg-6 sesqui(benzotriazolyl t-butyl hydroxyphenylpropionate) с аналогичной функцией и классификацией без известных рисков.
Проверь любой состав за 2 секунды
Скачай VeriMom бесплатно — отсканируй любой продукт и мгновенно получи оценку безопасности при беременности.
Медицинская оговорка
Данная информация предоставлена исключительно в образовательных целях и не является медицинской рекомендацией. Оценки безопасности основаны на общедоступных данных и могут не отражать все риски. Всегда консультируйтесь с вашим врачом перед использованием любых средств во время беременности или грудного вскармливания.